Solstice Advanced Materials enters July with a striking split in its positioning signals — options traders have turned sharply bullish just as short sellers add meaningfully to their bets against the stock.
The options market is sending the clearest near-term signal. The put/call ratio has collapsed to 0.31, roughly 1.3 standard deviations below its 20-day average of 1.01. That marks a near-complete reversal from the past six weeks: from late April through mid-June, the PCR ran consistently above 1.3, reflecting heavy downside hedging. Something shifted around June 19. Since then, call demand has dominated, pushing the ratio toward its 52-week low of 0.27. That kind of swing — from one of the most defensively positioned readings of the year to one of the most bullish — typically reflects either a catalyst-driven re-rating or a fresh round of speculative buying. The stock's 7.3% single-day gain on June 30, with a 4.6% weekly move to close at $88.60, suggests the momentum is genuine.
Short positioning tells a contrasting story, and it deserves attention. Short interest has climbed 36% over the past week and nearly 50% over the past month, now reaching 3.4% of the free float at 5.43 million shares. That is a meaningful acceleration in bearish positioning for a specialty chemicals name. Yet the borrow market remains almost entirely unconstrained — availability is running above 8,500% of existing short interest, meaning lenders are offering vastly more stock than shorts currently need. Cost to borrow is negligible at under 0.5%, near its one-month low. The combination of rising short interest and loose borrow conditions suggests this is not a squeeze-driven environment. Shorts are building positions calmly, without any urgency forcing them to cover.
On the Street, no fresh analyst activity is available within the standard lookback window. Valuation data through late June shows SOLS trading at a P/E of 30.1x and EV/EBITDA of 14.8x, both creeping higher over the past month. The P/E has expanded by roughly 1.2 points over thirty days, tracking the stock's own price appreciation. The price-to-book ratio of 7.1x has actually edged slightly lower over the same period, suggesting book value has grown modestly even as the share price climbed. An ORTEX short score of 34.6 places SOLS in the lower-moderate range — not a name the data flags as acutely at risk from short pressure, and the score has been broadly stable through the month.
Insider activity over the past 90 days has been routine rather than directional. The CAO received an award of 8,599 shares in mid-June and sold 3,244 shares on the same date — a standard tax-withholding pattern on vesting. The HR Director executed a similar award-and-sell pair in early June. Net insider flows over 90 days total roughly $980,000 on the sell side, entirely accounted for by these post-vesting disposals. There is no evidence of discretionary buying or selling from senior management.
Among correlated peers, the week's performance was notably mixed. DD fell 3.1% on the week while AVNT and ECL both rose roughly 3-4%. ESI added 4.1%. SOLS's 4.6% weekly gain broadly tracked the positive side of the peer group rather than diverging from it, suggesting at least partial sector tailwinds contributed to the move. The next scheduled event is earnings on August 5 — the prior two prints each saw a meaningful one-day swing (both times a move of 5-7%) followed by a recovery over the following week, so the setup into that date will be worth monitoring as it approaches.
See the live data behind this article on ORTEX.
Open SOLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
